Zobrazeno 1 - 10
of 31
pro vyhledávání: '"JR Kilborn"'
Autor:
Waterford, Stephen D.1 (AUTHOR), Ad, Niv2 (AUTHOR) nivadmd14@gmail.com
Publikováno v:
Rambam Maimonides Medical Journal. Jan2024, Vol. 15 Issue 1, p1-7. 7p.
Publikováno v:
British Journal of Clinical Pharmacology. 8:409P-708P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca9d0dc9d8b6558c5957a29dbc50ac5
https://doi.org/10.1111/j.1365-2125.1979.tb04756.x
https://doi.org/10.1111/j.1365-2125.1979.tb04756.x
Publikováno v:
British Journal of Clinical Pharmacology. 10:449-452
1 In normal subjects, intravenous betaxolol given in doses which inhibited the tachycardia of exercise failed to affect the peak expiratory flow rate. 2 From 2 to 48 h after administration of 150 micrograms/kg in four normal subjects, there was no si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7e9590cd3fb3aa9fca1db938cafb7a
https://doi.org/10.1111/j.1365-2125.1980.tb01787.x
https://doi.org/10.1111/j.1365-2125.1980.tb01787.x
Autor:
Thebault Jj, Lücker Pw, G Bianchetti, S Trocherie, R Gomeni, Blatrix C, JR Kilborn, Paolo L. Morselli, Larribaud J
Publikováno v:
British Journal of Clinical Pharmacology. 8:408P-708P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec513c72e99d053995d82764357c7b7c
https://doi.org/10.1111/j.1365-2125.1979.tb04755.x
https://doi.org/10.1111/j.1365-2125.1979.tb04755.x
Autor:
M Chauvin, C Richer, Christian Thuillez, G Bianchetti, R Gomeni, Jean-François Giudicelli, JR Kilborn, Paolo L. Morselli
Publikováno v:
British Journal of Clinical Pharmacology. 8:407P-708P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca32e9edb53852f6bd97504067ba8e31
https://doi.org/10.1111/j.1365-2125.1979.tb04754.x
https://doi.org/10.1111/j.1365-2125.1979.tb04754.x
Publikováno v:
British journal of clinical pharmacology. 8(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28041c815b4119518b068a9592289dd4
https://pubmed.ncbi.nlm.nih.gov/41557
https://pubmed.ncbi.nlm.nih.gov/41557
Publikováno v:
European journal of clinical pharmacology. 21(3)
1. Six healthy male volunteers received equivalent intravenous beta-blocking doses of propranolol, practolol and betaxolol (SL75212) or saline at weekly intervals Sixty minutes later 0.1 unit/kg insulin was given intravenously. 2. In all studies, max
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d3f4a51f58a1ad985d86bcf70f18c8
https://pubmed.ncbi.nlm.nih.gov/6119203
https://pubmed.ncbi.nlm.nih.gov/6119203
Autor:
P. J. Cadigan, R Gomeni, G Bianchetti, JR Kilborn, London, B. L. Pentecost, Paolo L. Morselli
Publikováno v:
British journal of clinical pharmacology. 9(6)
1 The effects of betaxolol (SL 75212), a new beta-adrenoceptor blocking agent, on the cardiovascular response to exercise have been studied in six normal subjects after placebo and single oral doses of 5, 10, 20 and 40 mg given double-blind in a rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c24d61d9c1dbfae8a147114528a825
https://pubmed.ncbi.nlm.nih.gov/6104498
https://pubmed.ncbi.nlm.nih.gov/6104498
Autor:
Maiolino, R.1,2 (AUTHOR) r.maiolino@mrao.cam.ac.uk, Mannucci, F.3 (AUTHOR)
Publikováno v:
Astronomy & Astrophysics Review. Dec2019, Vol. 27, p1-187. 187p.
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. Aug2017, Vol. 121 Issue 2, p89-97. 9p.